LEVINE WEIGHS IN ON PARP INHIBITOR ADVANCES IN OVARIAN CANCER
Douglas Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center, NYU Langone School of Medicine, sat down with… View more
Douglas Levine, MD, director of the Division of Gynecologic Oncology at Perlmutter Cancer Center, NYU Langone School of Medicine, sat down with… View more
NEW YORK , June 20, 2017 /PRNewswire/ — Tina’s Wish, the only nonprofit organization dedicated exclusively to funding scientific research for the early… View more
In 1995 I dodged a bullet, big time. I was diagnosed with stage one uterine cancer for which the treatment was surgery—a… View more
Dana-Farber scientist Dipanjan Chowdhury, PhD, whose research aims to discover and validate early-detection biomarkers for ovarian cancer, has been chosen for funding… View more
Tina’s Wish, the only nonprofit organization dedicated exclusively to funding scientific research for the early detection of ovarian cancer announced its eight… View more
Tina’s Wish, a nonprofit organization dedicated exclusively to funding scientific research for the early detection of ovarian cancer, recently announced its eight… View more